Wolfe Research Upgrades Broadcom to Outperform, $400 Price Target

Analyst: Chris Caso 1 min read Reproduced verbatim
Rating
Outperform
from Peer Perform
Target
$400
Outcome
Reached
on April 17, 2026
Wolfe Research and Broadcom logos

What the analyst said

Wolfe Research analyst Chris Caso upgraded Broadcom Limited (NASDAQ: AVGO) from Peer Perform to Outperform with a price target of $400.00.

“We upgrade AVGO to Outperform with a PT $400. We can no longer ignore the growth / competitiveness TPU, which checks suggest will grow to 7mn units annually by CY28.

GOOGL’s willingness to make TPU available to 3rd parties creates a true competitor to NVDA, and we expect AVGO to remain the main beneficiary.

As a result, we raise our CY27 ests to $154.5bn / $16 EPS, resulting in a 21x multiple.

Further upside to our CY27 estimates can be driven by other XPU ramps not in numbers – Meta, OAI, etc.

Estimates. We revise our CY26 AI ASIC revenue ~$44bn, reflecting 3.3mn TPU shipments, and revise our CY27 AI revenue to $78.4bn, reflecting ~5.1mn TPU shipments.

We assume TPU drives the majority of XPU growth, with all other projects 17% / 14% of XPU revenue in CY26/CY27, respectively.

We model Networking revenue $15.1bn or up ~75% y/y in CY26, consistent with our NVDA Networking revenue estimate; we model CY27 AI Networking revenue up ~55% y/y.

We leave our non-AI semis & Infrastructure Software estimates unchanged. Valuation.

We see ~$16 in EPS by CY27, putting the stock at a ~25x multiple, with a bull case of ~$18 EPS if AVGO can double its AI revenue again in CY27.

Our PT of ~$400 represents ~22x our bull case earnings power of $18, below AVGO’s 3-YR average ~25x multiple (i.e., since the beginning of the AI spending cycle).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AVGO trades at $326. The 21 analysts who set a target in the last 3 months range from $400 to $630, with a median of $515. This $400 target is 22% below the median, the lowest on the Street.

Since the note AVGO has moved −1% (from $331). 12-month window: day 275 of 365, closes on January 30, 2027.

Track record

This call✓ Target reached on April 17, 2026, 3 months after the note.

Firm track recordWolfe Research: 89% of its 9 targets at least a year old were reached within 12 months. Accuracy ranking →

Wolfe Research on Broadcom

Wolfe Research price targets on Broadcom

7 calls from March 7, 2025 to June 4, 2026. The target went from $400 to $500 (+25%). The rating moved from Hold to Buy.

Wolfe Research targetAVGO share price
  1. June 4, 2026Kept the $500 targetBuy$500
  2. May 14, 2026Target raised from $420 (+19%)Buy$500
  3. March 5, 2026Target raised from $400 (+5%)Buy$420
  4. January 30, 2026 This noteUpgraded to Buy, set a $400 targetBuy$400
  5. October 13, 2025Rating only, no price targetHoldNo target
  6. September 5, 2025Rating only, no price targetHoldNo target
  7. March 7, 2025Earliest call shownHoldNo target
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.